In a decisive move to tackle quality issues in pharmaceutical excipients, the Drugs Consultative Committee (DCC) of the Union health ministry has recommended stringent measures. The recent meeting, chaired by Drugs Controller General of India (DCGI) Dr Rajeev Singh Raghuvanshi, emphasized the necessity of adhering to the Drugs and Cosmetics Act for the use of only pharma-grade excipients.